Evidence map›Paper›PMID 34730375›Full record

ArticlemSphere2021

Molecular Analysis of

Kayoko Sugita, Kotaro Aoki, Kohji Komori, Tatsuya Nagasawa, Yoshikazu Ishii, Satoshi Iwata, Kazuhiro Tateda

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Mobile genetic elements of global Escherichia coli ST131 clades with carbapenemases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Article
  7. Detection of clinicalHeliyon · 2024
    Article
  8. Article
  9. Dissemination ofInfection and drug resistance · 2024
    Article
  10. Plasmid genomic epidemiology ofAntimicrobial agents and chemotherapy · 2023
    Article
  11. Genetic Characterization of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kayoko SugitaDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Kotaro AokiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.ORCID 0000-0002-9237-1217
Kohji KomoriDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Tatsuya NagasawaDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-1943-4648
Satoshi IwataDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Kazuhiro TatedaDepartment of Microbiology and Infectious Diseases, Toho University Graduate School of Medicine, Tokyo, Japan.
Toho University · JPKeio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of Klebsiella pneumoniae carbapenemase (KPC)-producing

Indexed as

Gene Transfer, HorizontalBacterial Proteinsbeta-LactamasesCitrobacterEnterobacteriaceae InfectionsHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsMorganella morganiiPlasmidsWhole Genome SequencingBacterial Proteinsbeta-Lactamasescarbapenemase-2, Klebsiella pneumoniaeblaKPC-2KPC-producing organismsplasmidTn4401aWGS

Identifiers

PMID34730375
PMCPMC8565517
OpenAlexW3208942143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.